Welcome to the Allergy Therapeutics Investor Relations Centre.

"We continue to execute our strategy to create significant value for our shareholders."

Manuel Llobet - CEO
Interim Results 2019 Webcast link

Dial-in details: +44 (0) 2071 928000 / Code 6619359

Annual Report 2018

2018 was a solid year for Allergy Therapeutics as we made important progress in key areas across the Company.

AT_Cover.jpg